COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData Read more
rVSV-ZEBOV vaccine first real-world data support prophylactic use for future Ebola outbreaks: GlobalData Read more
Gilead’s Livdelzi wins FDA approval, can challenge Ocaliva dominance in primary biliary cholangitis market Read more
Top 20 global biopharma companies report 4.3% growth in market capitalisation in Q2 2024, reveals GlobalData Read more
Obesity drug tirzepatide approval in China strengthens market position amid GLP-1 agonist competition: GlobalData Read more